Lilly (Eli) & Co. (LLY) Sector
Health Care

(Current) $767.76
-43.59 (-5.37%) Open Price: 767.76

 

Eli Lilly and Company, commonly known as Lilly, is a pharmaceutical company that was founded in 1876 and is listed on the New York Stock Exchange (NYSE) under the ticker symbol "LLY.". It is headquartered in Indianapolis, Indiana, USA. Lilly specializes in the research, development, and manufacture of innovative pharmaceutical products for various therapeutic areas, including neuroscience, endocrinology, oncology, immunology, and more. The company's mission is to make life better through the discovery, development, and delivery of innovative medicines that help people live healthier, more fulfilling lives.

 

Lilly is a global company with operations in numerous countries and serves patients in over 125 countries worldwide. The company's product portfolio includes both patented prescription drugs and generic medications. Some of Lilly's well-known products include Humalog (insulin), Cialis (erectile dysfunction), and Prozac (antidepressant).

 

Lilly has achieved several special achievements throughout its history. The company has been at the forefront of medical innovation, developing breakthrough treatments and therapies that have significantly impacted patient care. For example, Lilly's development of insulin revolutionized the treatment of diabetes and has saved countless lives worldwide.

 

The company has also made notable contributions in the field of neuroscience. Lilly has developed medications to treat various neurological disorders such as Alzheimer's disease, depression, and schizophrenia. These advancements have brought hope to patients and caregivers dealing with these challenging conditions.

 

Furthermore, Lilly has a strong commitment to research and development, investing significant resources into discovering and advancing new treatment options. The company collaborates with academic institutions, healthcare organizations, and other industry partners to drive innovation and improve patient outcomes.

 



 

(12/20/24) $767.76
(12/21/24) $811.35
(12/21/24) (Qty.)9,092,872
(12/20/24) $766.61
(12/20/24) $811.35
(12/15/24) $752.40
(12/01/24) $846.46
Stocktwits
LetsEncrypt SSL Secure Stripe Payment Processing